Physical Exercise and Nutrition in Functional Gastrointestinal Disorders in Obese Children

Sponsor
Meir Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06017856
Collaborator
(none)
180
1
14
12.8

Study Details

Study Description

Brief Summary

A prospective observational case-control study evaluating the effect of a weight loss intervention program on functional gastrointestinal disorders among overweight and obese children.

Condition or Disease Intervention/Treatment Phase
  • Other: Life style intervention program

Detailed Description

We intend to conduct a prospective observational case-control study of overweight and obese children, aged 6-18 years, followed in the child health and sport center at Meir medical center, Kfar-Saba, Israel.

Overweight and obese subjects, defined as body mass index (BMI) percentile ≥85%, will be offered to participate. Healthy subjects with normal BMI percentile from other pediatric outpatient clinics as well as relatives and friends of physicians from the pediatric division will be enrolled and serve as the control group.

Study visits will be at enrollment and after 3 and 6 months of participation in the intervention program. During the visits we will collect anthropometric measurements (height, weight, BMI, total body fat). Participants (age 10y and above) or their parents (age 6-10y) will fill a validated questionnaire for diagnosis of FGID based on ROME IV criteria. We will also collect data from exercise capability testing and quality of life questionnaires performed regularly (and irrespective of this study) during the intervention program.

We will then compare between subjects who succeeded to those who failed in losing at least 5% of their initial body weight as well as to healthy controls with normal BMI percentile.

Study Design

Study Type:
Observational
Anticipated Enrollment :
180 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Impact of Physical Exercise and Nutrition on Functional Gastrointestinal Disorders in Obese Children
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2024
Anticipated Study Completion Date :
Nov 1, 2024

Arms and Interventions

Arm Intervention/Treatment
obese and overweight

Overweight and obese subjects, defined as body mass index (BMI) percentile ≥85%, participating the in life-style intervention program in the child sport center at Meir medical center

Other: Life style intervention program
Life style intervention program for the obese/overweight subjects conducted regardless of this study at the child sport and health center at Meir medical center

normal weight

normal weight subjects defined as body mass index (BMI) percentile <85%, with no other chronic conditions

Outcome Measures

Primary Outcome Measures

  1. Diagnosis of functional gastrointestinal disorder [6 months]

    Diagnosis of functional gastrointestinal disorder according to the Rome IV criteria

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • obese / overweight children participating in the life style modification program at the child sport and health center
Exclusion Criteria:
  • other known chronic non-functional gastrointestinal conditions (e.g. Celiac disease, inflammatory bowel disease)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Meir Medical Center Kfar Saba Israel 4464402

Sponsors and Collaborators

  • Meir Medical Center

Investigators

  • Principal Investigator: Eyal Zifman, MD, Meir Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
eyal zifman, Head of pediatric gastroeneterogy service, Meir Medical Center
ClinicalTrials.gov Identifier:
NCT06017856
Other Study ID Numbers:
  • MMC-22-0199
First Posted:
Aug 30, 2023
Last Update Posted:
Aug 30, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by eyal zifman, Head of pediatric gastroeneterogy service, Meir Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 30, 2023